3078 related articles for article (PubMed ID: 7490128)
1. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
Ma D; Niederkorn JY
Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
[TBL] [Abstract][Full Text] [Related]
2. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
Ma D; Luyten GP; Luider TM; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
[TBL] [Abstract][Full Text] [Related]
3. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
4. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
6. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells.
Repp AC; Mayhew ES; Apte S; Niederkorn JY
J Immunol; 2000 Jul; 165(2):710-5. PubMed ID: 10878343
[TBL] [Abstract][Full Text] [Related]
7. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
8. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.
Pende D; Accame L; Pareti L; Mazzocchi A; Moretta A; Parmiani G; Moretta L
Eur J Immunol; 1998 Aug; 28(8):2384-94. PubMed ID: 9710216
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.
Yang H; Dithmar S; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2056-64. PubMed ID: 15223777
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
[TBL] [Abstract][Full Text] [Related]
12. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
13. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
14. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
15. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
Lin Y; Proud G; Taylor RM; Kirby JA
Immunology; 1993 Jun; 79(2):290-7. PubMed ID: 8344707
[TBL] [Abstract][Full Text] [Related]
16. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.
Versteeg R; Peltenburg LT; Plomp AC; Schrier PI
J Immunol; 1989 Dec; 143(12):4331-7. PubMed ID: 2512356
[TBL] [Abstract][Full Text] [Related]
17. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines.
Blom DJ; De Waard-Siebinga I; Apte RS; Luyten GP; Niederkorn JY; Jager MJ
Melanoma Res; 1997 Apr; 7(2):103-9. PubMed ID: 9167175
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye.
Apte RS; Niederkorn JY
J Immunol; 1996 Apr; 156(8):2667-73. PubMed ID: 8609381
[TBL] [Abstract][Full Text] [Related]
19. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R
Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392
[TBL] [Abstract][Full Text] [Related]
20. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]